Inventor
Michael D. Mullican
Inventor
Needham, MA, US
Overview
Patents· 52 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds26%
A61KPreparations for medical, dental or toiletry purposes22%
C07KPeptides18%
Y02ATechnologies for adaptation to climate change6%
C07CAcyclic or carbocyclic compounds1%
PatentTitleYear
8,691,848'Inhibitors of caspases'20148,119,631'Inhibitors of interleukin-1β converting enzyme'20127,790,713'Inhibitors of interleukin-1β converting enzyme'20107,772,366'Inhibitors of interleukin-1β converting enzyme'20107,358,273'Inhibitors of caspases'20087,288,624'Inhibitors of interleukin-1β converting enzyme'20077,226,919'Compositions useful as inhibitors of protein kinases'20077,109,215'Compounds possessing neuronal activity'20067,105,546'Acyclic and cyclic amine derivatives'20067,078,209'CAK inhibitors and uses thereof'20067,056,944'Pyrazole compositions useful as inhibitors of erk'20066,974,809'Inhibitors of interleukin 1-β converting enzyme'20056,747,042'N-heterocyclic derivatives'20046,716,860'Azo amino acids derivatives'20046,699,865'Pyrazole compositions useful as inhibitors of ERK'20046,677,359'N-substituted glycine derivatives'20046,660,748'Bicyclic derivatives'20036,593,357'Pyrazole compositions useful as inhibitors of ERK'20036,573,259'Inhibitors of interleukin-1 converting enzyme'20036,552,041'Cyclized amide derivatives'20036,531,474'Inhibitors of caspases'20036,528,533'Azo amino acids derivatives'20036,528,509'Pyrazole compositions useful as inhibitors of ERK'20036,426,413'Inhibitors of caspases'20026,423,840'Inhibitors of interleukin-1 converting enzyme'20026,420,522'Inhibitors of interleukin-1 converting enzyme'20026,350,741'Inhibitors of interleukin-1 converting enzyme'20026,329,365'Inhibitors of interleukin-1.beta. converting enzyme'20016,268,384'Compounds possessing neuronal activity'20016,258,948'Inhibitors of Interleukin-1.beta. converting enzyme'20016,204,261'Inhibitors of interleukin-1.beta. Converting enzyme inhibitors'20016,162,790'Inhibitors of interleukin-1.beta. converting enzyme'20006,103,711'Inhibitors of interleukin-1.beta. converting enzyme'20006,025,147'Inhibitors of interleukin-1 .beta. converting enzyme'20006,008,217'Inhibitors of interleukin-1.beta. converting enzyme'19995,973,111'Inhibitors of interleukin-1.beta. converting enzyme'19995,874,424'Inhibitors of interleukin-1.beta. converting enzyme'19995,847,135'Inhibitors of interleukin-1.beta. converting enzyme'19985,843,904'Inhibitors of interleukin-1.beta.converting enzyme'19985,756,466'Inhibitors of interleukin-1.beta. converting enzyme'19985,716,929'Inhibitors of interleukin-1.beta. converting enzyme'19985,656,627'Inhibitors of interleukin-1.beta. converting enzyme'19975,376,670'3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxyphenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents'19945,331,006'Amino acid analogs as CCK antagonists'19945,256,680'3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxy-phenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents'19935,155,122'3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxy-phenyl-1,2,4-thiadazoles, oxadiazoles and triazoles as antiinflammatory agents'19925,102,897'3,5-ditertiarybutyl-4-hydroxyphenyl, 1,3,4-thiadiazoles and oxadiazoles linked by carbon, oxygen, and sulfur residues'19924,931,459'Method for treating acute respirator distress syndrome'19904,910,317'Benzofurans and benzothiophenes having antiallergic activity and method of use thereof'19904,824,958'Process for the preparation of n-1H-tetrazol-5-yl-2-pyrrole carboxamides'19894,764,525'N-1H-tetrazol-5-ylbenzamides having use as antiallergy and antiinflammatory agents'19884,748,183'N-1H-tetrazol-5-yl-2-thiophene carboxamides, N-1H-tetrazol-5-yl-2-pyrrole carboxamides, N-1H-tetrazol-5-yl-2-furan carboxamides, and anti-allergic and anti-inflammatory use thereof'1988Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1988–1994Patents assigned to WARNER LAMBERT CO (10)· patent assignee history
1988–1994Based in Ypsilanti, MI, US· patent location history
1997–2014Patents assigned to VERTEX PHARMA (41)· patent assignee history
1997–2014Based in Needham, MA, US· patent location history
2012–2014Patents assigned to BEMIS GUY W (2)· patent assignee history
2012–2014Patents assigned to LAUFFER DAVID J (2)· patent assignee history
2012–2014Patents assigned to MULLICAN MICHAEL D (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VERTEX PHARMA | 41 | 1997–2014 |
| WARNER LAMBERT CO | 10 | 1988–1994 |
| BEMIS GUY W | 2 | 2012–2014 |
| LAUFFER DAVID J | 2 | 2012–2014 |
| MULLICAN MICHAEL Dself | 2 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Needham, Massachusetts, US | 42 | 1997–2014 |
| Ypsilanti, MI, US | 10 | 1988–1994 |